Recombinant Therapeutic Molecules Produced in Plants

Advances in Botanical Research

Volumn 86, Issue , 2018, Pages 207-244

  Chen, Qiang ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Flavivirus; Monoclonal antibody; Nicotiana benthamiana; Plant expression system; Plant made biologics; Plant made pharmaceutical; Therapeutic enzymes; Transient expression; Vaccine; Virus like particle

Indexed keywords

EID: 85043366363     PISSN: 00652296     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.abr.2017.11.006     Document Type: Chapter

References (97)

1. Abbink, P., Larocca, R.A., De La Barrera, R.A., Bricault, C.A., Moseley, E.T., Boyd, M., et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science, 353(6304), 2016, 1129 Retrieved from http://science.sciencemag.org/content/353/6304/1129.abstract.
2. Arntzen, C., Plant-made pharmaceuticals: From ‘edible vaccines’ to Ebola therapeutics. Plant Biotechnology Journal 13:8 (2015), 1013–1016, 10.1111/pbi.12460.
3. Attar, N., ZIKA virus circulates in new regions. Nature Reviews Microbiology, 14(2), 2016, 62, 10.1038/nrmicro.2015.28.
4. Ausar, S.F., Foubert, T.R., Hudson, M.H., Vedvick, T.S., Middaugh, C.R., Conformational stability and disassembly of Norwalk virus like particles: Effect of pH and temperature. The Journal of Biological Chemistry 281:28 (2006), 19478–19488, 10.1074/jbc.M603313200.
5. Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S., et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Annals of Oncology 21:12 (2010), 2420–2427, 10.1093/annonc/mdq256.
6. Bethell, D.R., Generally recognized as safe (GRAS) notification for lactoferrin (human) from rice for use as an ingredient in pediatric medical foods and oral rehydration solutions. 2007.
7. Cao-Lormeau, V.-M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. The Lancet 387:10027 (2016), 1531–1539, 10.1016/S0140-6736(16)00562-6.
8. Check Hayden, E., Reardon, S., Should experimental drugs be used in the Ebola outbreak?. Nature (London), 2014 https://doi.org/10.1038/nature.2014.15698.
9. Chen, Q., Expression and purification of pharmaceutical proteins in plants. Biological Engineering 1:4 (2008), 291–321.
10. Chen, Q., Expression and manufacture of pharmaceutical proteins in genetically engineered horticultural plants. Mou, B., Scorza, R., (eds.) Transgenic horticultural crops: Challenges and opportunities—Essays by experts, 2011, Taylor & Francis, Boca Raton, 83–124.
11. Chen, Q., Virus-like particle vaccines for Norovirus gastroenteritis. Giese, M., (eds.) Molecular vaccine, Vol. 1, 2013, Springer, Vienna, 153–181, 10.1007/978-3-7091-1419-3_8.
12. Chen, Q., Plant-made vaccines against West Nile virus are potent, safe, and economically feasible. Biotechnology Journal 10:5 (2015), 671–680, 10.1002/biot.201400428.
13. Chen, Q., Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms. Proceedings of the National Academy of Sciences of the United States of America 113:34 (2016), 9404–9406, 10.1073/pnas.1610803113.
14. Chen, Q., & Davis, K. (2016). The potential of plants as a system for the development and production of human biologics F1000Research, 5(912), doi: 10.12688/f11000research.18010.12681. Retrieved from http://f1000r.es/6nf.
15. Chen, Q., Dent, M., Hurtado, J., Stahnke, J., McNulty, A., Leuzinger, K., et al. Transient protein expression by agroinfiltration in lettuce. Menassa, R., Macdonald, J., Kolotilin, I., (eds.) Recombinant proteins from plants, 2, 2014.
16. Chen, Q., Dent, M., Hurtado, J., Stahnke, J., McNulty, A., Leuzinger, K., et al. Transient protein expression by agroinfiltration in lettuce. Methods in Molecular Biology 1385 (2016), 55–67, 10.1007/978-1-4939-3289-4_4.
17. Chen, X., Equi, R., Baxter, H., Berk, K., Han, J., Agarwal, S., et al. A high-throughput transient gene expression system for switchgrass (Panicum virgatum L.) seedlings. Biotechnology for Biofuels, 3, 2010, 9.
18. Chen, Q., He, J., Phoolcharoen, W., Mason, H.S., Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Human Vaccines 7:3 (2011), 331–338 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21358270.
19. Chen, Q., Lai, H., Plant-derived virus-like particles as vaccines. Human Vaccines & Immunotherapeutics 9:1 (2013), 26–49 Retrieved from http://www.landesbioscience.com/journals/vaccines/article/22218/.
20. Chen, Q., Lai, H., Gene delivery into plant cells for recombinant protein production. BioMed Research International, 2014, 2014, 10, 10.1155/2014/932161.
21. Chen, Q., Lai, H., Plant-derived monoclonal antibodies as human biologics for infectious disease and cancer. Hefferon, K.L., (eds.) Plant-derived pharmaceuticals: Principles and applications for developing countries, 2014, CABI, Croydon, UK, 42–75.
22. Chen, Q., Lai, H., The growing potential of plant-made monoclonal antibodies. Drug Target Review 2:4 (2015), 41–44 Retrieved from http://www.drugtargetreview.com/8059/drug-target-review-journal/issue-4-2015/protein-expression-the-growing-potential-of-plant-made-monoclonal-antibodies/.
23. Chen, Q., Lai, H., & He, J. (2016). Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration, US patent # US 9499608 B2. Retrieved from http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/9499608.
24. Chen, B.J., Leser, G.P., Morita, E., Lamb, R.A., Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. Journal of Virology 81:13 (2007), 7111–7123 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17475660.
25. Chen, Q., Mason, H., Mor, T., Cardineau, G.A., Arntzen, C., Tacket, C.O., Subunit vaccines produced using plant biotechnology. Levine, M.M., (eds.) New generation vaccines, 4th ed., 2009, Informa Healthcare USA, Inc., New York, 306–315.
26. Chen, Q., Zhang, C., Santi, L., Plant-made biologics. BioMed Research International, 2014, 2014, 3, 10.1155/2014/418064.
27. Daniell, H., GM crops: Public perception and scientific solutions. Trends in Plant Science 4:12 (1999), 467–469, 10.1016/S1360-1385(99)01503-4.
28. Daniell, H., Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnology Journal 1:10 (2006), 1071–1079 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17004305.
29. D'Aoust, M.A., Couture, M.M., Charland, N., Trepanier, S., Landry, N., Ors, F., et al. The production of hemagglutinin-based virus-like particles in plants: A rapid, efficient and safe response to pandemic influenza. Plant Biotechnology Journal 8:5 (2010), 607–619 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20199612.
30. Dent, M., Hurtado, J., Paul, A.M., Sun, H., Lai, H., Yang, M., et al. Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity. Journal of General Virology 97:12 (2016), 3280–3290, 10.1099/jgv.0.000635.
31. Dugdale, B., Mortimer, C.L., Kato, M., James, T.A., Harding, R.M., Dale, J.L., Plant activation: An inducible, hyperexpression platform for recombinant protein production in plants. The Plant Cell Online 25:7 (2013), 2429–2443, 10.1105/tpc.113.113944.
32. Fox, J.L., First plant-made biologic approved. Nature Biotechnology, 30(6), 2012, 472, 10.1038/nbt0612-472.
33. Fulton, A., Lai, H., Chen, Q., Zhang, C., Purification of monoclonal antibody against Ebola GP1 protein expressed in Nicotiana benthamiana. Journal of Chromatography A 1389:0 (2015), 128–132 https://doi.org/10.1016/j.chroma.2015.02.013.
34. Giritch, A., Marillonnet, S., Engler, C., van Eldik, G., Botterman, J., Klimyuk, V., et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proceedings of the National Academy of Sciences of the United States of America 103:40 (2006), 14701–14706 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16973752.
35. Gleba, Y., Tusé, D., Giritch, A., Plant viral vectors for delivery by agrobacterium. Palmer, K., Gleba, Y., (eds.) Plant viral vectors, Vol. 375, 2014, Springer Berlin Heidelberg, 155–192.
36. He, J., Lai, H., Brock, C., Chen, Q., A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants. Journal of Biomedicine and Biotechnology 2012 (2012), 1–10, 10.1155/2012/106783.
37. He, J., Lai, H., Engle, M., Gorlatov, S., Gruber, C., Steinkellner, H., et al. Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus. PLoS One, 9(3), 2014, e93541, 10.1371/journal.pone.0093541.
38. He, Y., Ning, T., Xie, T., Qiu, Q., Zhang, L., Sun, Y., et al. Large-scale production of functional human serum albumin from transgenic rice seeds. Proceedings of the National Academy of Sciences of the United States of America 108:47 (2011), 19078–19083, 10.1073/pnas.1109736108.
39. He, J., Peng, L., Lai, H., Hurtado, J., Stahnke, J., Chen, Q., A plant-produced antigen elicits potent immune responses against West Nile virus in mice. BioMed Research International, 2014, 2014, 10, 10.1155/2014/952865.
40. Henao-Restrepo, A.M., Camacho, A., Longini, I.M., Watson, C.H., Edmunds, W.J., Egger, M., et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: Final results from the Guinea ring vaccination, open-label, cluster-randomised trial. The Lancet 389:10068 (2017), 505–518, 10.1016/S0140-6736(16)32621-6.
41. Herbst-Kralovetz, M., Mason, H.S., Chen, Q., Norwalk virus-like particles as vaccines. Expert Review of Vaccines 9:3 (2010), 299–307, 10.1586/erv.09.163.
42. Hey, C., Zhang, C., Process development for antibody purification from tobacco by protein A affinity chromatography. Chemical Engineering & Technology 35:1 (2012), 142–148, 10.1002/ceat.201100259.
43. Hiwasa-Tanase, K., Ezura, H., Molecular breeding to create optimized crops: From genetic manipulation to potential applications in plant factories. Frontiers in Plant Science, 7, 2016, 539, 10.3389/fpls.2016.00539.
44. Hjelm, B.E., Kilbourne, J., Herbst-Kralovetz, M.M., TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines. Human Vaccines & Immunotherapeutics 10:2 (2014), 410–416, 10.4161/hv.27147.
45. Huang, Z., Chen, Q., Hjelm, B., Arntzen, C., Mason, H., A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnology and Bioengineering 103:4 (2009), 706–714 Retrieved from https://doi.org/10.1002/bit.22299.
46. Huang, Z., Phoolcharoen, W., Lai, H., Piensook, K., Cardineau, G., Zeitlin, L., et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnology and Bioengineering 106:1 (2010), 9–17 Retrieved from https://doi.org/10.1002/bit.22652.
47. Jiang, X., Wang, M., Graham, D.Y., Estes, M.K., Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. Journal of Virology 66:11 (1992), 6527–6532.
48. Klee, H., Horsch, R., Rogers, S., Agrobacterium-mediated plant transformation and its further applications to plant biology. Annual Review of Plant Physiology 38 (1987), 467–486.
49. Komarova, T.V., Baschieri, S., Donini, M., Marusic, C., Benvenuto, E., Dorokhov, Y.L., Transient expression systems for plant-derived biopharmaceuticals. Expert Review of Vaccines 9:8 (2010), 859–876, 10.1586/erv.10.85.
50. Kwon, K.-C., Daniell, H., Low-cost oral delivery of protein drugs bioencapsulated in plant cells. Plant Biotechnology Journal 13:8 (2015), 1017–1022, 10.1111/pbi.12462.
51. Lai, H., Chen, Q., Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Reports 31:3 (2012), 573–584 Retrieved from https://doi.org/10.1007/s00299-011-1196-6.
52. Lai, H., Engle, M., Fuchs, A., Keller, T., Johnson, S., Gorlatov, S., et al. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proceedings of the National Academy of Sciences of the United States of America 107:6 (2010), 2419–2424, 10.1073/pnas.0914503107.
53. Lai, H., He, J., Engle, M., Diamond, M.S., Chen, Q., Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnology Journal 10:1 (2012), 95–104 Retrieved from https://doi.org/10.1111/j.1467-7652.2011.00649.x.
54. Lai, H., He, J., Hurtado, J., Stahnke, J., Fuchs, A., Mehlhop, E., et al. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnology Journal 12:8 (2014), 1098–1107, 10.1111/pbi.12217.
55. Lakshmi, P.S., Verma, D., Yang, X., Lloyd, B., Daniell, H., Low cost tuberculosis vaccine antigens in capsules: Expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS One, 8(1), 2013, e54708, 10.1371/journal.pone.0054708.
56. Larocca, R.A., Abbink, P., Peron, J.P.S., Zanotto, P.M., Iampietro, M.J., Badamchi-Zadeh, A., et al. Vaccine protection against Zika virus from Brazil. Nature 536:7617 (2016), 474–478, 10.1038/nature18952.
57. Leuzinger, K., Dent, M., Hurtado, J., Stahnke, J., Lai, H., Zhou, X., et al. Efficient agroinfiltration of plants for high-level transient expression of recombinant proteins. Journal of Visualized Experiments, 77, 2013, 10.3791/50521 Retrieved from http://www.jove.com/video/50521.
58. Lico, C., Chen, Q., Santi, L., Viral vectors for production of recombinant proteins in plants. Journal of Cellular Physiology 216:2 (2008), 366–377 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18330886.
59. Loos, A., Gruber, C., Altmann, F., Mehofer, U., Hensel, F., Grandits, M., et al. Expression and glycoengineering of functionally active heteromultimeric IgM in plants. Proceedings of the National Academy of Sciences of the United States of America 111:17 (2014), 6263–6268, 10.1073/pnas.1320544111.
60. Lyon, G.M., Mehta, A.K., Varkey, J.B., Brantly, K., Plyler, L., McElroy, A.K., et al. Clinical care of two patients with Ebola virus disease in the United States. New England Journal of Medicine 371:25 (2014), 2402–2409, 10.1056/NEJMoa1409838.
61. Ma, J.K.C., Drossard, J., Lewis, D., Altmann, F., Boyle, J., Christou, P., et al. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnology Journal 13:8 (2015), 1106–1120, 10.1111/pbi.12416.
62. Maruyama, N., Fujiwara, K., Yokoyama, K., Cabanos, C., Hasegawa, H., Takagi, K., et al. Stable accumulation of seed storage proteins containing vaccine peptides in transgenic soybean seeds. Journal of Bioscience and Bioengineering 118:4 (2014), 441–447, 10.1016/j.jbiosc.2014.04.004.
63. McCormick, A.A., Reddy, S., Reinl, S.J., Cameron, T.I., Czerwinkski, D.K., Vojdani, F., et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study. Proceedings of the National Academy of Sciences of the United States of America 105:29 (2008), 10131–10136, 10.1073/pnas.0803636105.
64. Morandini, F., Avesani, L., Bortesi, L., Van Droogenbroeck, B., De Wilde, K., Arcalis, E., et al. Non-food/feed seeds as biofactories for the high-yield production of recombinant pharmaceuticals. Plant Biotechnology Journal 9:8 (2011), 911–921, 10.1111/j.1467-7652.2011.00605.x.
65. Morens, D.M., Antibody-dependent of enhancement of infection and the pathogenesis of viral disease. Clinical Infectious Diseases 19 (1994), 500–512.
66. Olinger, G.G., Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America 109:44 (2012), 18030–18035, 10.1073/pnas.1213709109.
67. Pardi, N., Weissman, D., Nucleoside modified mRNA vaccines for infectious diseases. Kramps, T., Elbers, K., (eds.) RNA vaccines: Methods and protocols, 2017, Springer New York, New York, NY, 109–121.
68. Phoolcharoen, W., Bhoo, S.H., Lai, H., Ma, J., Arntzen, C.J., Chen, Q., et al. Expression of an immunogenic Ebola immune complex in Nicotiana Benthamiana. Plant Biotechnology Journal 9:7 (2011), 807–816 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21281425.
69. Phoolcharoen, W., Dye, J.M., Kilbourne, J., Piensook, K., Pratt, W.D., Arntzen, C.J., et al. A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proceedings of the National Academy of Sciences of the United States of America 108:51 (2011), 20695–20700, 10.1073/pnas.1117715108.
70. Pogue, G., Vojdani, F., Palmer, K.C., Hiatt, E., Hume, S., Phelps, J., et al. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnology Journal 8:5 (2010), 638–654 Retrieved from https://doi.org/10.1111/j.1467-7652.2009.00495.x.
71. Pushko, P., Bray, M., Ludwig, G.V., Parker, M., Schmaljohn, A., Sanchez, A., et al. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19:1 (2000), 142–153 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10924796.
72. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J.B., et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514:7520 (2014), 47–53, 10.1038/nature13777.
73. Ramessar, K., Rademacher, T., Sack, M., Stadlmann, J., Platis, D., Stiegler, G., et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proceedings of the National Academy of Sciences of the United States of America 105:10 (2008), 3727–3732, 10.1073/pnas.0708841104.
74. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. Journal of Experimental Medicine 189:2 (1999), 371–380 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9892619.
75. Richardson, J.S., Yao, M.K., Tran, K.N., Croyle, M.A., Strong, J.E., Feldmann, H., et al. Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS One, 4(4), 2009, e5308 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19390586.
76. Rivera, A., Gomez-Lim, M., Fernandez, F., Loske, A., Physical methods for genetic plant transformation. Physics of Life Reviews 9:3 (2012), 308–345 Retrieved from http://www.sciencedirect.com/science/article/pii/S1571064512000498.
77. Roque, A.C.A., Lowe, C.R., Taipa, M.A., Antibodies and genetically engineered related molecules: Production and purification. Biotechnology Progress 20:3 (2004), 639–654 Retrieved from http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/bp030070k.
78. Santi, L., Batchelor, L., Huang, Z., Hjelm, B., Kilbourne, J., Arntzen, C.J., et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26:15 (2008), 1846–1854 https://doi.org/10.1016/j.vaccine.2008.01.053.
79. Santi, L., Huang, Z., Mason, H., Virus-like particles production in green plants. Methods 40:1 (2006), 66–76 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16997715.
80. Schulz, S., Stephan, A., Hahn, S., Bortesi, L., Jarczowski, F., Bettmann, U., et al. Broad and efficient control of major foodborne pathogenic strains of Escherichia coli by mixtures of plant-produced colicins. Proceedings of the National Academy of Sciences of the United States of America 112:40 (2015), E5454–E5460, 10.1073/pnas.1513311112.
81. Shaaltiel, Y., Gingis-Velitski, S., Tzaban, S., Fiks, N., Tekoah, Y., Aviezer, D., Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease. Plant Biotechnology Journal 13:8 (2015), 1033–1040, 10.1111/pbi.12366.
82. Stoger, E., Vaquero, C., Torres, E., Sack, M., Nicholson, L., Drossard, J., et al. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Molecular Biology 42:4 (2000), 583–590 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10809004.
83. Strasser, R., Stadlmann, J., Schahs, M., Stiegler, G., Quendler, H., Mach, L., et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnology Journal 6:4 (2008), 392–402, 10.1111/j.1467-7652.2008.00330.x.
84. Su, J., Sherman, A., Doerfler, P.A., Byrne, B.J., Herzog, R.W., Daniell, H., Oral delivery of acid alpha glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice. Plant Biotechnology Journal 13:8 (2015), 1023–1032, 10.1111/pbi.12413.
85. Su, J., Zhu, L., Sherman, A., Wang, X., Lin, S., Kamesh, A., et al. Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B. Biomaterials 70 (2015), 84–93 https://doi.org/10.1016/j.biomaterials.2015.08.004.
86. Takaiwa, F., Yang, L., Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies. Transgenic Research 23:4 (2014), 573–584, 10.1007/s11248-014-9790-3.
87. Takata, N., Eriksson, M.E., A simple and efficient transient transformation for hybrid aspen (Populus tremula x P. tremuloides). Plant Methods, 8(1), 2012, 30 Retrieved from http://www.plantmethods.com/content/8/1/30.
88. Thuenemann, E.C., Meyers, A.E., Verwey, J., Rybicki, E.P., Lomonossoff, G.P., A method for rapid production of heteromultimeric protein complexes in plants: Assembly of protective bluetongue virus-like particles. Plant Biotechnology Journal 11:7 (2013), 839–846 Retrieved from https://doi.org/10.1111/pbi.12076.
89. Tuse, D., Tu, T., McDonald, K., Manufacturing economics of plant-made biologics: Case studies in therapeutic and industrial enzymes. BioMed Research International 2014:256135 (2014), 1–16, 10.1155/2014/256135.
90. Vaghchhipawala, Z., Rojas, C.M., Senthil-Kumar, M., Mysore, K.S., Agroinoculation and agroinfiltration: Simple tools for complex gene function analyses. Methods in Molecular Biology 678 (2011), 65–76 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20931373.
91. Walsh, G., Biopharmaceutical benchmarks 2014. Nature Biotechnology 32:10 (2014), 992–1000, 10.1038/nbt.3040.
92. Yang, M., Dent, M., Lai, H., Sun, H., Chen, Q., Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Vacccine 35:33 (2017), 4287–4294 https://.doi.org/10.1016/j.vaccine.2017.04.052.
93. Yang, M., Lai, H., Sun, H., Chen, Q., Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Scientific Reports, 7(1), 2017, 7679, 10.1038/s41598-017-08247-9.
94. Yang, M., Sun, H., Lai, H., Hurtado, J., Chen, Q., Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice. Plant Biotechnology Journal, 2017, 10.1111/pbi.12796.
95. Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N., Kim, D., Pauly, M., et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proceedings of the National Academy of Sciences of the United States of America 108:51 (2011), 20690–20694, 10.1073/pnas.1108360108.
96. Zhang, X., Buehner, N.A., Hutson, A.M., Estes, M.K., Mason, H.S., Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnology Journal 4:4 (2006), 419–432 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17177807.
97. Zimran, A., Brill-Almon, E., Chertkoff, R., Petakov, M., Blanco-Favela, F., Munoz, E.T., et al. Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 118:22 (2011), 5767–5773, 10.1182/blood-2011-07-366955.